Clinical Trials Browser

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT03455270 2022-12-15

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

Phase 1 Completed

107 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT02684032 2022-07-27

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Phase 1 Completed

141 enrolled

Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT01976169 2022-02-08

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

Phase 1 Completed

29 enrolled

Breast

Breast Neoplasms

NCT01320592 2020-04-08

PD0332991/Paclitaxel in Advanced Breast Cancer

Phase 1 Completed

28 enrolled

Breast

Breast Neoplasms

NCT02065063 2018-06-01

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors

Phase 1 Completed

28 enrolled

Dermatologic

Melanoma, Neoplasms

NCT00420056 2015-10-28

An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.

Phase 1 Completed

17 enrolled 22 charts

Lymphoid

Lymphoma, Mantle-Cell

NCT01602887 2012-11-12

Relative Bioavailability Study

Phase 1 Completed

24 enrolled

Breast

Breast Neoplasms